Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy

PURPOSE: Comparison of overall survival (OS) between stereotactic body radiation therapy (SBRT) and other treatments for early-stage non-small cell lung cancer is confounded by differences in age, performance status, and medical comorbidity. We sought to define the most robust measurement for this p...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pract Radiat Oncol
Hlavní autoři: DeWees, Todd A., Nikitas, John, Rehman, Sana, Bradley, Jeffrey D., Robinson, Cliff G., Roach, Michael C.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6321777/
https://ncbi.nlm.nih.gov/pubmed/30244094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prro.2018.09.001
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky